

<!DOCTYPE html>
<html lang="zh-CN" >



<head>
  <meta charset="UTF-8">

  <link rel="apple-touch-icon" sizes="76x76" href="/img/Logo.png">
  <link rel="icon" href="/img/Logo.png">
  

  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0, shrink-to-fit=no">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  
  <meta name="theme-color" content="#2f4154">
  <meta name="author" content="向海">
  <meta name="keywords" content="">
  
    <meta name="description" content="Drugs about heart">
<meta property="og:type" content="article">
<meta property="og:title" content="L8 Agents used in Heart Failure and Cardiac Arrhythmias">
<meta property="og:url" content="https://zhenyumi.github.io/posts/71c1856d/index.html">
<meta property="og:site_name" content="鹘横海">
<meta property="og:description" content="Drugs about heart">
<meta property="og:locale" content="zh_CN">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330104052287.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330104216380.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330104710885.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330104717492.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210331110924603.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210331110929888.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210331111729428.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210331115648413.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401111840470.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401114802586.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401114830500.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401114945757.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401114954618.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401115033154.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401115543262.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401115645709.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401115653883.png">
<meta property="article:published_time" content="2021-04-16T06:03:09.000Z">
<meta property="article:modified_time" content="2021-04-16T06:03:09.000Z">
<meta property="article:author" content="向海">
<meta property="article:tag" content="Molecular Pharmacology">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330104052287.png">
  
  
  
  <title>L8 Agents used in Heart Failure and Cardiac Arrhythmias - 鹘横海</title>

  <link  rel="stylesheet" href="https://lib.baomitu.com/twitter-bootstrap/4.6.1/css/bootstrap.min.css" />



  <link  rel="stylesheet" href="https://lib.baomitu.com/github-markdown-css/4.0.0/github-markdown.min.css" />

  <link  rel="stylesheet" href="https://lib.baomitu.com/hint.css/2.7.0/hint.min.css" />

  <link  rel="stylesheet" href="https://lib.baomitu.com/fancybox/3.5.7/jquery.fancybox.min.css" />



<!-- 主题依赖的图标库，不要自行修改 -->
<!-- Do not modify the link that theme dependent icons -->

<link rel="stylesheet" href="//at.alicdn.com/t/c/font_1749284_5i9bdhy70f8.css">



<link rel="stylesheet" href="//at.alicdn.com/t/c/font_1736178_k526ubmyhba.css">


<link  rel="stylesheet" href="/css/main.css" />


  <link id="highlight-css" rel="stylesheet" href="/css/highlight.css" />
  




  <script id="fluid-configs">
    var Fluid = window.Fluid || {};
    Fluid.ctx = Object.assign({}, Fluid.ctx)
    var CONFIG = {"hostname":"zhenyumi.github.io","root":"/","version":"1.9.8","typing":{"enable":true,"typeSpeed":70,"cursorChar":"_","loop":false,"scope":["home"]},"anchorjs":{"enable":true,"element":"h1,h2,h3,h4,h5,h6","placement":"left","visible":"hover","icon":""},"progressbar":{"enable":true,"height_px":3,"color":"#29d","options":{"showSpinner":false,"trickleSpeed":100}},"code_language":{"enable":true,"default":"TEXT"},"copy_btn":true,"image_caption":{"enable":true},"image_zoom":{"enable":true,"img_url_replace":["",""]},"toc":{"enable":true,"placement":"right","headingSelector":"h1,h2,h3,h4,h5,h6","collapseDepth":0},"lazyload":{"enable":true,"loading_img":"/img/loading.gif","onlypost":false,"offset_factor":2},"web_analytics":{"enable":false,"follow_dnt":true,"baidu":null,"google":{"measurement_id":null},"tencent":{"sid":null,"cid":null},"leancloud":{"app_id":null,"app_key":null,"server_url":null,"path":"window.location.pathname","ignore_local":false},"umami":{"src":null,"website_id":null,"domains":null,"start_time":"2024-01-01T00:00:00.000Z","token":null,"api_server":null}},"search_path":"/local-search.xml","include_content_in_search":true};

    if (CONFIG.web_analytics.follow_dnt) {
      var dntVal = navigator.doNotTrack || window.doNotTrack || navigator.msDoNotTrack;
      Fluid.ctx.dnt = dntVal && (dntVal.startsWith('1') || dntVal.startsWith('yes') || dntVal.startsWith('on'));
    }
  </script>
  <script  src="/js/utils.js" ></script>
  <script  src="/js/color-schema.js" ></script>
  


  
<meta name="generator" content="Hexo 7.0.0"></head>


<body>
  

  <header>
    

<div class="header-inner" style="height: 70vh;">
  <nav id="navbar" class="navbar fixed-top  navbar-expand-lg navbar-dark scrolling-navbar">
  <div class="container">
    <a class="navbar-brand" href="/">
      <strong>鹘横海</strong>
    </a>

    <button id="navbar-toggler-btn" class="navbar-toggler" type="button" data-toggle="collapse"
            data-target="#navbarSupportedContent"
            aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
      <div class="animated-icon"><span></span><span></span><span></span></div>
    </button>

    <!-- Collapsible content -->
    <div class="collapse navbar-collapse" id="navbarSupportedContent">
      <ul class="navbar-nav ml-auto text-center">
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/" target="_self">
                <i class="iconfont icon-home-fill"></i>
                <span>首页</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/archives/" target="_self">
                <i class="iconfont icon-archive-fill"></i>
                <span>归档</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/categories/" target="_self">
                <i class="iconfont icon-category-fill"></i>
                <span>分类</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/tags/" target="_self">
                <i class="iconfont icon-tags-fill"></i>
                <span>标签</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/about/" target="_self">
                <i class="iconfont icon-user-fill"></i>
                <span>关于</span>
              </a>
            </li>
          
        
        
          <li class="nav-item" id="search-btn">
            <a class="nav-link" target="_self" href="javascript:;" data-toggle="modal" data-target="#modalSearch" aria-label="Search">
              <i class="iconfont icon-search"></i>
            </a>
          </li>
          
        
        
      </ul>
    </div>
  </div>
</nav>

  

<div id="banner" class="banner" parallax=true
     style="background: url('https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/Fluid/post/post2.jpg') no-repeat center center; background-size: cover;">
  <div class="full-bg-img">
    <div class="mask flex-center" style="background-color: rgba(0, 0, 0, 0.3)">
      <div class="banner-text text-center fade-in-up">
        <div class="h2">
          
            <span id="subtitle">L8 Agents used in Heart Failure and Cardiac Arrhythmias</span>
          
        </div>

        
          
  <div class="mt-3">
    
    
      <span class="post-meta">
        <i class="iconfont icon-date-fill" aria-hidden="true"></i>
        <time datetime="2021-04-16 14:03" pubdate>
          2021年4月16日 下午
        </time>
      </span>
    
  </div>

  <div class="mt-1">
    
      <span class="post-meta mr-2">
        <i class="iconfont icon-chart"></i>
        
          370 字
        
      </span>
    

    
      <span class="post-meta mr-2">
        <i class="iconfont icon-clock-fill"></i>
        
        
        
          4 分钟
        
      </span>
    

    
    
  </div>


        
      </div>

      
    </div>
  </div>
</div>

</div>

  </header>

  <main>
    
      

<div class="container-fluid nopadding-x">
  <div class="row nomargin-x">
    <div class="side-col d-none d-lg-block col-lg-2">
      

    </div>

    <div class="col-lg-8 nopadding-x-md">
      <div class="container nopadding-x-md" id="board-ctn">
        <div id="board">
          <article class="post-content mx-auto">
            <h1 id="seo-header">L8 Agents used in Heart Failure and Cardiac Arrhythmias</h1>
            
            
              <div class="markdown-body">
                
                <img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330104052287.png" srcset="/img/loading.gif" lazyload alt="image-20210330104052287" style="zoom: 50%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330104216380.png" srcset="/img/loading.gif" lazyload alt="image-20210330104216380" style="zoom:100%;" />

<h1 id="一、Heart-Failure"><a href="#一、Heart-Failure" class="headerlink" title="一、Heart Failure"></a>一、Heart Failure</h1><p>Results from any structural or functional abnormality that impairs the ability of the ventricle to eject blood (<strong>Systolic Heart Failure</strong>) or to fill with blood (<strong>Diastolic Heart Failure</strong>)</p>
<p><strong>Systolic failure</strong>: reduced mechanical pumping action (contractility)and reduced ejection fraction: failure in <strong>excitation-contraction coupling</strong></p>
<p><strong>Diastolic failure:</strong> stiffening and loss of adequate <strong>relaxation</strong> results in reduced filling and cardiac output</p>
<p>Final common pathway for many cardiovascular diseases whose natural history results in symptomatic or asymptomatic <strong>left ventricular</strong> <strong>dysfunction (less blood coming out of heart)</strong></p>
<p>Cardinal manifestations of heart failure include dyspnea (呼吸困难) , fatigue and pulmonary edema </p>
<p>Risk of death is 5-10% annually in patients with mild symptoms and increases to as high as 30-40% annually in patients with advanced disease</p>
<h2 id="Overview-of-congestive-heart-failure"><a href="#Overview-of-congestive-heart-failure" class="headerlink" title="Overview of congestive heart failure"></a>Overview of congestive heart failure</h2><p>Congestive heart failure (CHF) is a condition in which the heart is unable to pump sufficient blood to meet the needs of body. </p>
<p>CHF can be caused by increased workload imposed on the heart. </p>
<p>CHF is accompanied by abnormal increases in blood volume and interstitial fluid; the heart, veins, and capillaries are therefore generally dilated with blood. </p>
<p>symptoms include pulmonary congestion with left heart failure, and peripheral edema with right heart failure. </p>
<p>Underlying causes of CHF include arteriosclerotic heart disease, hypertensive heart disease, valvular heart disease(心瓣膜病), dilated cardiomyopathy(扩张性心肌病), and congenital heart disease(先天性心脏病)</p>
<h2 id="The-Vicious-Cycle-of-Heart-Failure"><a href="#The-Vicious-Cycle-of-Heart-Failure" class="headerlink" title="The Vicious Cycle of Heart Failure"></a>The Vicious Cycle of Heart Failure</h2><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330104710885.png" srcset="/img/loading.gif" lazyload alt="image-20210330104710885" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330104717492.png" srcset="/img/loading.gif" lazyload alt="image-20210330104717492" style="zoom: 50%;" />

<ul>
<li>NE: Norepinephrine; </li>
<li>AII: Angiotensisn II</li>
<li>ET: Endothelin;</li>
<li>Therefore, targeting the SNS and RAS,together with vasodilators, will help to treat HF</li>
</ul>
<h2 id="Compensatory-changes-in-heart-failure"><a href="#Compensatory-changes-in-heart-failure" class="headerlink" title="Compensatory changes in heart failure"></a>Compensatory changes in heart failure</h2><p><strong>Activation of Sympathetic Nerve System</strong></p>
<p><strong>Activation of Renin-Angiotensin System</strong></p>
<p>Increased heart rate</p>
<p>Release of Aldosterone Hormone (vaso-constriction)</p>
<p>Release of atrial natriuretic peptide 心钠素</p>
<p>Chamber enlargement 心室腔扩大</p>
<p>Myocardial hypertrophy 心室肥厚</p>
<h1 id="二、Cardiac-Contractility"><a href="#二、Cardiac-Contractility" class="headerlink" title="二、Cardiac Contractility"></a>二、Cardiac Contractility</h1><h2 id="Control-of-normal-cardiac-contractility"><a href="#Control-of-normal-cardiac-contractility" class="headerlink" title="Control of normal cardiac contractility"></a>Control of normal cardiac contractility</h2><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210331110924603.png" srcset="/img/loading.gif" lazyload alt="image-20210331110924603" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210331110929888.png" srcset="/img/loading.gif" lazyload alt="image-20210331110929888" style="zoom:100%;" />

<ol>
<li>Sensitivity of contractile proteins to calcium </li>
<li>Amount of calcium released from SR </li>
<li>Amount of calcium stored in SR </li>
<li>Amount of trigger calcium entering cell </li>
<li>Activity of sodium-calcium antiporter 6.Activity of Na+&#x2F;K+-ATPase</li>
</ol>
<h2 id="Strategy-of-treatment-of-CHF"><a href="#Strategy-of-treatment-of-CHF" class="headerlink" title="Strategy of treatment of CHF"></a>Strategy of treatment of CHF</h2><p><strong>The therapeutic goal for CHF is to increase cardiac output</strong></p>
<ol>
<li>Inotropic agents that increase the strength of contraction of cardiac muscle </li>
<li>PDEI (phosphodiesterase inhibitors) agents that increase cAMP to induce systoles and vasodilatation </li>
<li>Calcium sensitizers extracellular fluid volume </li>
<li>β adrenergic agonist </li>
<li>β adrenergic antagonist </li>
<li>Vasodilators: Calcium channel blocker </li>
<li>Decreasing RAS activity: ACEI and AT1 antagonist </li>
<li>Diuretic agents</li>
</ol>
<h2 id="Treatment-of-congestive-heart-failure"><a href="#Treatment-of-congestive-heart-failure" class="headerlink" title="Treatment of congestive heart failure"></a>Treatment of congestive heart failure</h2><h3 id="1-Positive-inotropic-drugs"><a href="#1-Positive-inotropic-drugs" class="headerlink" title="1. Positive inotropic drugs"></a>1. Positive inotropic drugs</h3><ol>
<li>Cardiac glycosides</li>
<li>β-adrenergic agonists (New dopamine receptor agonist)</li>
<li>phosphodiesterase inhibitors </li>
<li>Calcium sensitizers</li>
</ol>
<h4 id="Cardiac-glycosides-强心苷类"><a href="#Cardiac-glycosides-强心苷类" class="headerlink" title="Cardiac glycosides&#x2F;强心苷类"></a>Cardiac glycosides&#x2F;强心苷类</h4><p>An inotrope is an agent that alters the force or energy of muscular contractions. <strong>Negatively inotropic agents</strong> weaken the force of muscular contractions. <strong>Positively inotropic agents</strong> <u>increase the strength of muscular contraction</u></p>
<ul>
<li>prevent calcium efflux</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210331111729428.png" srcset="/img/loading.gif" lazyload alt="image-20210331111729428" style="zoom:100%;" />

<ul>
<li>The Unsaturated lactone（不饱和内酯环）Convey cardiotonic activity</li>
<li>The steroid nucleus（甾核）Convey the pharmacological activity</li>
<li>The Sugars- 3 mols. of digitoxose (3分子洋地黄毒糖) Modulate potency and pharmacokinetic distribution</li>
</ul>
<h5 id="1-Machanism-of-cardiac-glycoside-on-positive-inotropic-action"><a href="#1-Machanism-of-cardiac-glycoside-on-positive-inotropic-action" class="headerlink" title="(1) Machanism of cardiac glycoside on positive inotropic action"></a>(1) Machanism of cardiac glycoside on positive inotropic action</h5><ol>
<li>Inhibiting Na+-K+-ATPase in therapeutic dose:</li>
<li>Increasing of calcium inward and induce the releasing of calcium from sarcoplasmic reticulum</li>
</ol>
<h5 id="2-Pharmacologic-action"><a href="#2-Pharmacologic-action" class="headerlink" title="(2) Pharmacologic action"></a>(2) Pharmacologic action</h5><p><strong>Action of cardiac glycosides on the heart</strong></p>
<ul>
<li>Positive inotropic action：Increasing contractility of cardiac muscle in heart failure.<ul>
<li><strong>characteristic:</strong>	<ul>
<li>myocardiac quick contraction↓ <ul>
<li>rate of force ↑</li>
<li>time to peak tension ↓</li>
</ul>
</li>
</ul>
</li>
<li>Effect of positive inotropic act<ul>
<li>cardiac output is increased</li>
<li>compensatory sympathetic tone is reduced</li>
<li>cardiac preload and afterload is decreased</li>
<li>heart rate is reduced</li>
<li>myocardiac fiber tone and oxygen consumption is decreased</li>
</ul>
</li>
</ul>
</li>
<li>Negative chronotropic (heart-rate change) action<ul>
<li>Continuous effect of positive inotropic action → increased cardiac output, heart rate is decreased (due to dereased sympathetic tone)</li>
<li><strong>Chronotropic</strong> drugs may change the heart rate and rhythm by affecting the electrical conduction system of the heart and the nerves that influence it, such as by changing the rhythm produced by the sinoatrial node. Positive chronotropes increase heart rate; negative chronotropes decrease heart rate.</li>
<li>The CO is determined by heart rate and muscle contraction strength</li>
</ul>
</li>
</ul>
<h5 id="3-Clinical-uses"><a href="#3-Clinical-uses" class="headerlink" title="(3) Clinical uses"></a>(3) Clinical uses</h5><p>Cardiac glycosides are given for CHF</p>
<ul>
<li>，<ul>
<li><strong>Best</strong> ：go with atrial fibrillation</li>
<li><strong>Better</strong>：hypertension congenital heart disease</li>
</ul>
</li>
</ul>
<p>Some kinds of arrhythmias (abnormal heart rate)</p>
<ul>
<li>Atrial fibrillation </li>
<li>Atrial flutter</li>
<li>Supraventricular Tachycardia</li>
</ul>
<h4 id="β-Adrenoceptor-agonists"><a href="#β-Adrenoceptor-agonists" class="headerlink" title="β-Adrenoceptor agonists"></a>β-Adrenoceptor agonists</h4><p>They are used intravenously in CHF <strong>emergencies</strong></p>
<p>Example of β-Adrenoceptor agonists :</p>
<p>Dobutamine (多巴酚丁胺)</p>
<ul>
<li>Exciting β1 Adrenoceptor → positive inotropic action →the volume of output↑</li>
<li>Exciting β2 Adrenoceptor→dilate the vascular → afterload↓</li>
</ul>
<p>have benefits within short time</p>
<h4 id="Phosphodiesterase-Ⅲ-inhibitors"><a href="#Phosphodiesterase-Ⅲ-inhibitors" class="headerlink" title="Phosphodiesterase-Ⅲ inhibitors"></a>Phosphodiesterase-Ⅲ inhibitors</h4><p>Inodilator &#x2F; inodilating drugs</p>
<ul>
<li>Inhibiting the activity of PDE Ⅲ → cAMP↑→ causes an increase in myocardial contractility and vasodilatation →total peripheral resistance ↓ →cardiac output ↑</li>
</ul>
<p>Examples:</p>
<ul>
<li><strong>Armirinone（氨力农）</strong>: Inhibits the excess product of NO, TNF and affects the neurohormone, anti-the forming of thrombus</li>
<li><strong>milrinone（米力农）</strong>: stronger 20 time</li>
<li><strong>vesnarinone（维司力农）</strong>: myocardial contract element’s<br>the sensitivity to calcium ↑</li>
</ul>
<h4 id="Calcium-sensitizers"><a href="#Calcium-sensitizers" class="headerlink" title="Calcium sensitizers"></a>Calcium sensitizers</h4><p><strong>Pimobendan</strong> 匹莫苯:</p>
<ul>
<li>Inhibit PDE Ⅲ ; increase TnC’s sensitivity to calcium</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210331115648413.png" srcset="/img/loading.gif" lazyload alt="image-20210331115648413" style="zoom:100%;" />

<p>Tn troponin—肌钙蛋白；myosin－肌球蛋白；tropomyosin－原 ；Actin 肌动蛋白</p>
<h3 id="2-Diuretics"><a href="#2-Diuretics" class="headerlink" title="2. Diuretics"></a>2. Diuretics</h3><p>Diuretics <strong>inhibit</strong> sodium and water retention, →reduce the volume of blood, →venous pressure and the thus cardiac preload are reduced↓, increasing the efficiency of the heart as a pump→ cardiac output ↑, so reduce oedema due to heart failure</p>
<p>Heart failure</p>
<ul>
<li>Low-grade : Thiazides hydrochlorothiazide 氢氯噻嗪</li>
<li>Higher-grade : Acute left heart failure</li>
<li>loop diuretics — furosemide 呋塞米（速尿）</li>
<li><strong>Spironolacton</strong> 螺内酯<ul>
<li>（anti-aldosterone ,keep potassium and diuretics)</li>
</ul>
</li>
</ul>
<h3 id="3-Vasodilators"><a href="#3-Vasodilators" class="headerlink" title="3. Vasodilators"></a>3. Vasodilators</h3><ol>
<li>Calcium channel blocker </li>
<li>Nitryl-vasodilators</li>
<li>Hydralazine</li>
</ol>
<h4 id="Angiotensin-converting-enzyme-inhibitor-ACEI"><a href="#Angiotensin-converting-enzyme-inhibitor-ACEI" class="headerlink" title="Angiotensin-converting-enzyme inhibitor (ACEI )"></a>Angiotensin-converting-enzyme inhibitor (ACEI )</h4><p>Example: <strong>Captopril Enalapril</strong></p>
<p>Methanism of anti-CHF:</p>
<ol>
<li>Humour: <strong>Inhibit ACE→angiotensin Ⅱ and aldosterone levels↓</strong>, reduce sodium retention, increase bradykinin levels , ANP、 NO、PGI2↑, reduce the release of NA ET and renew the expression of βreceptor</li>
<li>This therefore <u>causes vasodilatation</u> (include coronary artery) →reduction in peripheral resistance→ increase the cardiac output, Increase the blood flow of kidney so Improve the function of kidney</li>
<li>Prevent the <u>remodel of the heart</u></li>
</ol>
<p>vesodilation → reduce preload</p>
<h4 id="AT1-antiagonists"><a href="#AT1-antiagonists" class="headerlink" title="AT1 antiagonists"></a>AT1 antiagonists</h4><p><strong>Losartan</strong> <strong>（氯沙坦）</strong></p>
<ul>
<li>The function just like ACEⅠ</li>
</ul>
<p><strong>Clinical utilize:</strong> </p>
<ul>
<li>CHF (<strong>Congestive heart failure</strong>)</li>
<li>Protection of kidneys</li>
</ul>
<h4 id="Calcium-channel-blockers"><a href="#Calcium-channel-blockers" class="headerlink" title="Calcium-channel blockers"></a>Calcium-channel blockers</h4><p>Amlodipine 氨氯地平</p>
<ul>
<li>Blood Vessel Targeting</li>
<li>Dilate artery</li>
<li>Dilate the coronary </li>
<li>Alleviate the LV Wall Tension</li>
</ul>
<h4 id="Others-–Vasodilators-for-phrephoiral"><a href="#Others-–Vasodilators-for-phrephoiral" class="headerlink" title="Others –Vasodilators: for phrephoiral"></a>Others –Vasodilators: for phrephoiral</h4><p>for heart failure patients, the pre and afterload should be both low by using drugs low afterload: prevent CO to decrease</p>
<p><strong>mechanism</strong>: Finally Decrease the oxygen demand of the heart</p>
<ul>
<li>Dilatation of the veins→ decreases preload</li>
<li>Dilatation of the artery→ decreases afterloads</li>
</ul>
<p>Examples:</p>
<ul>
<li>Nitrate esters: nitroglycerin , nitroprusside sodium 硝普纳</li>
<li>Hydralazine 肼屈嗪 direct dilate the vascular</li>
<li>Prazosin 哌唑嗪 ɑ-receptor blocker</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401111840470.png" srcset="/img/loading.gif" lazyload alt="image-20210401111840470" style="zoom:100%;" />

<h3 id="4-RAAS-inhibitors"><a href="#4-RAAS-inhibitors" class="headerlink" title="4. RAAS inhibitors"></a>4. RAAS inhibitors</h3><p>antiotensin converting enzyme inhibitor and AT1 antagonist</p>
<hr>
<p>Combine drugs to treat heart failure to increase CO and induce vessel dilation at the same time, to prevent entering into the vicious cycle </p>
<p>The same as combining drugs to treat HTN: inducing vessel dilation while decreasing CO</p>
<h1 id="三、Agents-used-in-Cardiac-Arrhythmias"><a href="#三、Agents-used-in-Cardiac-Arrhythmias" class="headerlink" title="三、Agents used in Cardiac Arrhythmias"></a>三、Agents used in Cardiac Arrhythmias</h1><h2 id="Definition-of-arrhythmia-irregular-heart-beat"><a href="#Definition-of-arrhythmia-irregular-heart-beat" class="headerlink" title="Definition of arrhythmia: irregular heart beat"></a>Definition of arrhythmia: irregular heart beat</h2><p>Arrhythmias and disrhythmias are the same thing. Cardiac arrhythmia is an abnormality of the heart rhythm</p>
<ul>
<li>Bradycardia – heart rate slow (&lt;60 beats&#x2F;min) 心动过缓</li>
<li>Tachycardia – heart rate fast (&gt;100 beats&#x2F;min) 心动过速</li>
</ul>
<p>Arrhythmias is common</p>
<ul>
<li>50% of anesthetized patients</li>
<li>80% of myocardial infarction patients</li>
</ul>
<p>Can cause diziness, loss of consciousness, or death</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401114802586.png" srcset="/img/loading.gif" lazyload alt="image-20210401114802586" style="zoom:100%;" />

<h2 id="Categories-of-arrhythmias"><a href="#Categories-of-arrhythmias" class="headerlink" title="Categories of arrhythmias"></a>Categories of arrhythmias</h2><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401114830500.png" srcset="/img/loading.gif" lazyload alt="image-20210401114830500" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401114945757.png" srcset="/img/loading.gif" lazyload alt="image-20210401114945757" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401114954618.png" srcset="/img/loading.gif" lazyload alt="image-20210401114954618" style="zoom:100%;" />

<h2 id="ECG"><a href="#ECG" class="headerlink" title="ECG"></a>ECG</h2><p>ECG is the body surface manifestion of the depolarization and repolarization waves of the heart</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401115033154.png" srcset="/img/loading.gif" lazyload alt="image-20210401115033154" style="zoom:100%;" />

<p>P: Atrial depolarization (<u>Site of origin</u> of the electrical impulse)</p>
<p>QRS: ventricle depolarization</p>
<p>T: ventricle repolarization</p>
<p>PR interval: a measure of <u>conduction time</u> from atrium to ventricle</p>
<p>QRS: the time required for all of the ventricular cells to be activated (the intraventricular <u>conduction</u> time)</p>
<p>QT: the duration of the ventricular action potential</p>
<h3 id="1-Cardiac-Electrophysiology"><a href="#1-Cardiac-Electrophysiology" class="headerlink" title="1. Cardiac Electrophysiology"></a>1. Cardiac Electrophysiology</h3><p>To understand the action and classification of the antiarrhythmic drugs, it is first necessary to understand the ionic movements that underlie the cardiac membrane potential</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401115543262.png" srcset="/img/loading.gif" lazyload alt="image-20210401115543262" style="zoom: 50%;" />

<p>The voltage change of the membrane potential is associated with the changes of ions across membrane, ie Na+, K+, and Ca2+</p>
<h3 id="2-Phases-of-action-potential-of-cardiac-cells"><a href="#2-Phases-of-action-potential-of-cardiac-cells" class="headerlink" title="2. Phases of action potential of cardiac cells"></a>2. Phases of action potential of cardiac cells</h3><p>A typical AP of ventricular muscle cell can be divided into 5 phases</p>
<p>Phase 0： rapid depolarisation – inflow of Na+</p>
<p>Phase 1：partial repolarization – inward Na+ of K+</p>
<p>Phase 2： plateau – slow inward calcium current</p>
<p>Phase 3：rapid repolarisation – calcium current inactivates, K+ outflow</p>
<p>Phase 4：pacemaker potential&#x2F;diastole </p>
<ul>
<li>Na+ outflow and K+ inflow by Na-KATPase</li>
<li>Autorhythmic cell : Na+ inflow to reach threshold potential</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401115645709.png" srcset="/img/loading.gif" lazyload alt="image-20210401115645709" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210401115653883.png" srcset="/img/loading.gif" lazyload alt="image-20210401115653883" style="zoom:100%;" />


                
              </div>
            
            <hr/>
            <div>
              <div class="post-metas my-3">
  
    <div class="post-meta mr-3 d-flex align-items-center">
      <i class="iconfont icon-category"></i>
      

<span class="category-chains">
  
  
    
      <span class="category-chain">
        
  <a href="/categories/Academic-Notebook/" class="category-chain-item">Academic Notebook</a>
  
  
    <span>></span>
    
  <a href="/categories/Academic-Notebook/Molecular-Pharmacology/" class="category-chain-item">Molecular Pharmacology</a>
  
  

  

      </span>
    
  
</span>

    </div>
  
  
    <div class="post-meta">
      <i class="iconfont icon-tags"></i>
      
        <a href="/tags/Molecular-Pharmacology/" class="print-no-link">#Molecular Pharmacology</a>
      
    </div>
  
</div>


              
  

  <div class="license-box my-3">
    <div class="license-title">
      <div>L8 Agents used in Heart Failure and Cardiac Arrhythmias</div>
      <div>https://zhenyumi.github.io/posts/71c1856d/</div>
    </div>
    <div class="license-meta">
      
        <div class="license-meta-item">
          <div>作者</div>
          <div>向海</div>
        </div>
      
      
        <div class="license-meta-item license-meta-date">
          <div>发布于</div>
          <div>2021年4月16日</div>
        </div>
      
      
      
        <div class="license-meta-item">
          <div>许可协议</div>
          <div>
            
              
              
                <a class="print-no-link" target="_blank" href="https://creativecommons.org/licenses/by/4.0/">
                  <span class="hint--top hint--rounded" aria-label="BY - 署名">
                    <i class="iconfont icon-cc-by"></i>
                  </span>
                </a>
              
            
          </div>
        </div>
      
    </div>
    <div class="license-icon iconfont"></div>
  </div>



              
                <div class="post-prevnext my-3">
                  <article class="post-prev col-6">
                    
                    
                      <a href="/posts/657d3ac8/" title="L9 Introduction to pharmacology of CSN drugs , sedatives and hypnotics">
                        <i class="iconfont icon-arrowleft"></i>
                        <span class="hidden-mobile">L9 Introduction to pharmacology of CSN drugs , sedatives and hypnotics</span>
                        <span class="visible-mobile">上一篇</span>
                      </a>
                    
                  </article>
                  <article class="post-next col-6">
                    
                    
                      <a href="/posts/a09a12e3/" title="L7 Antihypertensive drugs including Vasodilators and anti-diuretics">
                        <span class="hidden-mobile">L7 Antihypertensive drugs including Vasodilators and anti-diuretics</span>
                        <span class="visible-mobile">下一篇</span>
                        <i class="iconfont icon-arrowright"></i>
                      </a>
                    
                  </article>
                </div>
              
            </div>

            
          </article>
        </div>
      </div>
    </div>

    <div class="side-col d-none d-lg-block col-lg-2">
      
  <aside class="sidebar" style="margin-left: -1rem">
    <div id="toc">
  <p class="toc-header">
    <i class="iconfont icon-list"></i>
    <span>目录</span>
  </p>
  <div class="toc-body" id="toc-body"></div>
</div>



  </aside>


    </div>
  </div>
</div>





  



  



  



  



  


  
  









    

    
      <a id="scroll-top-button" aria-label="TOP" href="#" role="button">
        <i class="iconfont icon-arrowup" aria-hidden="true"></i>
      </a>
    

    
      <div class="modal fade" id="modalSearch" tabindex="-1" role="dialog" aria-labelledby="ModalLabel"
     aria-hidden="true">
  <div class="modal-dialog modal-dialog-scrollable modal-lg" role="document">
    <div class="modal-content">
      <div class="modal-header text-center">
        <h4 class="modal-title w-100 font-weight-bold">搜索</h4>
        <button type="button" id="local-search-close" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body mx-3">
        <div class="md-form mb-5">
          <input type="text" id="local-search-input" class="form-control validate">
          <label data-error="x" data-success="v" for="local-search-input">关键词</label>
        </div>
        <div class="list-group" id="local-search-result"></div>
      </div>
    </div>
  </div>
</div>

    

    
  </main>

  <footer>
    <div class="footer-inner">
  
    <div class="footer-content">
       <a href="https://hexo.io" target="_blank" rel="nofollow noopener"><span>Hexo</span></a> <i class="iconfont icon-love"></i> <a href="https://github.com/fluid-dev/hexo-theme-fluid" target="_blank" rel="nofollow noopener"><span>Fluid</span></a> 
    </div>
  
  
  
</div>

  </footer>

  <!-- Scripts -->
  
  <script  src="https://lib.baomitu.com/nprogress/0.2.0/nprogress.min.js" ></script>
  <link  rel="stylesheet" href="https://lib.baomitu.com/nprogress/0.2.0/nprogress.min.css" />

  <script>
    NProgress.configure({"showSpinner":false,"trickleSpeed":100})
    NProgress.start()
    window.addEventListener('load', function() {
      NProgress.done();
    })
  </script>


<script  src="https://lib.baomitu.com/jquery/3.6.4/jquery.min.js" ></script>
<script  src="https://lib.baomitu.com/twitter-bootstrap/4.6.1/js/bootstrap.min.js" ></script>
<script  src="/js/events.js" ></script>
<script  src="/js/plugins.js" ></script>





  
    <script  src="/js/img-lazyload.js" ></script>
  




  
<script>
  Fluid.utils.createScript('https://lib.baomitu.com/tocbot/4.20.1/tocbot.min.js', function() {
    var toc = jQuery('#toc');
    if (toc.length === 0 || !window.tocbot) { return; }
    var boardCtn = jQuery('#board-ctn');
    var boardTop = boardCtn.offset().top;

    window.tocbot.init(Object.assign({
      tocSelector     : '#toc-body',
      contentSelector : '.markdown-body',
      linkClass       : 'tocbot-link',
      activeLinkClass : 'tocbot-active-link',
      listClass       : 'tocbot-list',
      isCollapsedClass: 'tocbot-is-collapsed',
      collapsibleClass: 'tocbot-is-collapsible',
      scrollSmooth    : true,
      includeTitleTags: true,
      headingsOffset  : -boardTop,
    }, CONFIG.toc));
    if (toc.find('.toc-list-item').length > 0) {
      toc.css('visibility', 'visible');
    }

    Fluid.events.registerRefreshCallback(function() {
      if ('tocbot' in window) {
        tocbot.refresh();
        var toc = jQuery('#toc');
        if (toc.length === 0 || !tocbot) {
          return;
        }
        if (toc.find('.toc-list-item').length > 0) {
          toc.css('visibility', 'visible');
        }
      }
    });
  });
</script>


  <script src=https://lib.baomitu.com/clipboard.js/2.0.11/clipboard.min.js></script>

  <script>Fluid.plugins.codeWidget();</script>


  
<script>
  Fluid.utils.createScript('https://lib.baomitu.com/anchor-js/5.0.0/anchor.min.js', function() {
    window.anchors.options = {
      placement: CONFIG.anchorjs.placement,
      visible  : CONFIG.anchorjs.visible
    };
    if (CONFIG.anchorjs.icon) {
      window.anchors.options.icon = CONFIG.anchorjs.icon;
    }
    var el = (CONFIG.anchorjs.element || 'h1,h2,h3,h4,h5,h6').split(',');
    var res = [];
    for (var item of el) {
      res.push('.markdown-body > ' + item.trim());
    }
    if (CONFIG.anchorjs.placement === 'left') {
      window.anchors.options.class = 'anchorjs-link-left';
    }
    window.anchors.add(res.join(', '));

    Fluid.events.registerRefreshCallback(function() {
      if ('anchors' in window) {
        anchors.removeAll();
        var el = (CONFIG.anchorjs.element || 'h1,h2,h3,h4,h5,h6').split(',');
        var res = [];
        for (var item of el) {
          res.push('.markdown-body > ' + item.trim());
        }
        if (CONFIG.anchorjs.placement === 'left') {
          anchors.options.class = 'anchorjs-link-left';
        }
        anchors.add(res.join(', '));
      }
    });
  });
</script>


  
<script>
  Fluid.utils.createScript('https://lib.baomitu.com/fancybox/3.5.7/jquery.fancybox.min.js', function() {
    Fluid.plugins.fancyBox();
  });
</script>


  <script>Fluid.plugins.imageCaption();</script>

  
      <script>
        if (!window.MathJax) {
          window.MathJax = {
            tex    : {
              inlineMath: { '[+]': [['$', '$']] }
            },
            loader : {
              load: ['ui/lazy']
            },
            options: {
              renderActions: {
                insertedScript: [200, () => {
                  document.querySelectorAll('mjx-container').forEach(node => {
                    let target = node.parentNode;
                    if (target.nodeName.toLowerCase() === 'li') {
                      target.parentNode.classList.add('has-jax');
                    }
                  });
                }, '', false]
              }
            }
          };
        } else {
          MathJax.startup.document.state(0);
          MathJax.texReset();
          MathJax.typeset();
          MathJax.typesetPromise();
        }

        Fluid.events.registerRefreshCallback(function() {
          if ('MathJax' in window && MathJax.startup.document && typeof MathJax.startup.document.state === 'function') {
            MathJax.startup.document.state(0);
            MathJax.texReset();
            MathJax.typeset();
            MathJax.typesetPromise();
          }
        });
      </script>
    

  <script  src="https://lib.baomitu.com/mathjax/3.2.2/es5/tex-mml-chtml.js" ></script>

  <script  src="/js/local-search.js" ></script>





<!-- 主题的启动项，将它保持在最底部 -->
<!-- the boot of the theme, keep it at the bottom -->
<script  src="/js/boot.js" ></script>


  

  <noscript>
    <div class="noscript-warning">博客在允许 JavaScript 运行的环境下浏览效果更佳</div>
  </noscript>
</body>
</html>
